Vimarsana.com
4
5
6
7
8
9
10
Latest Breaking News On - Clinical surveillance - Page 3 : vimarsana.com
Wolters Kluwer Health Acquires AI Drug Diversion Detection Company Invistics
Kluwer Health acquires Invistics, an AI-enabled software for drug diversion detection and controlled substance compliance.
Invistics-corporation
Compliance-data-solutions
Wolters-kluwer-health
Clinical-solutions
Should-know
Kluwer-health
Clinical-surveillance
Data-solutions
National-institutes
Wolters Kluwer Acquires Invistics
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Netherlands
Tom-knight
Wolters-kluwer
Euronext
Invistics-corporation
Compliance-data-solutions
Clinical-solutions
Wolters-kluwer-health
Clinical-surveillance
Data-solutions
Euronext-amsterdam
Wolters Kluwer N.V.: Wolters Kluwer acquires U.S. AI-enabled drug diversion detection software
Wolters Kluwer acquires U.S. AI-enabled drug diversion detection software Technology leader seeks to help tackle growing drug diversion challenge in the U.S. Waltham, MA - June 7, 2023 - Wolters
United-states
Netherlands
Zeiten
Mecklenburg-vorpommern
Germany
American
Stefan-klotter
Meg-geldens
Wolters-kluwer
Paul-lyon
Tom-knight
Wolters-kluwer-healthtoday
Wolters Kluwer acquires U.S. AI-enabled drug diversion detection software
Technology leader seeks to help tackle growing drug diversion challenge in the U.S. . | June 7, 2023
United-states
Netherlands
American
Karen-kobelski
Wolters-kluwer
Tom-knight
Euronext
Compliance-data-solutions
Compliance-data-solutions-at-wolters-kluwer-health
Wolters-kluwer-health
Clinical-solutions
Invistics-corporation
Wolters Kluwer Acquires AI Drug Diversion Detection Company Invistics
Kluwer Health acquires Invistics, an AI-enabled software for drug diversion detection and controlled substance compliance.
Kluwer-health
Clinical-solutions
Invistics-corporation
Compliance-data-solutions
Should-know
Clinical-surveillance
Data-solutions
National-institutes
vimarsana © 2020. All Rights Reserved.